The looming December 2019 deadline for compliance with the requirements of both U.S. Pharmacopeial Convention (USP) General Chapters <800> and <797> on the handling of hazardous drugs and sterile compounding is driving a wave of pharmacy redesign and expansion at hospitals and health systems across the country.
For some institutions, renovations have been limited to the sterile compounding space, but in others, the new guidelines have provided an impetus to take on the